You are here

LY2605541

Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541

Yahoo/PR NewsWire

Sun, 06/23/13 - 11:19 am

type 1 diabetes

Eli Lilly's Big Bet On Diabetes

Seeking Alpha

Tue, 04/23/13 - 07:54 am

Lilly Backs Broad Diabetes Range to Challenge Rivals

Bloomberg

Mon, 10/8/12 - 12:53 pm

Boehringer Ingelheim

SGLT2 inhibitor